[1]
T. Ruzicka and Ring J., “Enhanced releasability of prostaglandin E2 and leukotrienes B4 and C4 from leukocytes of patients with atopic eczema”, Acta Derm Venereol, vol. 67, no. 6, pp. 469–475, Nov. 1987.